Interaction of drugs with P-glycoprotein in brain capillaries

Biochemical Pharmacology

Volumn 50, Issue 10, 1995, Pages 1701-1709

  Jetté, Lucie ^a   Murphy, Gérard F ^b   Leclerc, Jean Marie ^c   Béliveau, Richard ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^b (Canada) Inc   (Canada)

^c UNIVERSITY OF MONTREAL   (Canada)

Author keywords

brain capillaries; cyclosporin A; cyclosporin treatment; P glycoprotein; photolabeling; PSC 833

Indexed keywords

ARYLAZIDOPRAZOSIN; BILIRUBIN; COLCHICINE; CREMOPHOR; CYCLOSPORIN A; CYCLOSPORIN A DERIVATIVE; DACTINOMYCIN; DOXORUBICIN; DRUG VEHICLE; GLYCOPROTEIN P; IODINE 125; PROGESTERONE; QUINIDINE; RADIOISOTOPE; RESERPINE; SDZ 205536; UNCLASSIFIED DRUG; VALSPODAR; VERAPAMIL; VINBLASTINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING COMPETITION; BLOOD BRAIN BARRIER; BRAIN CAPILLARY; BRAIN TUMOR; CONTROLLED STUDY; ENDOTHELIUM CELL; MALE; NONHUMAN; PHOTOAFFINITY LABELING; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

AFFINITY LABELS; ANIMAL; AZIDES; BLOOD-BRAIN BARRIER; BRAIN; CAPILLARIES; CYCLOSPORINE; CYCLOSPORINS; DRUG INTERACTIONS; GLYCEROL; IN VITRO; IODINE RADIOISOTOPES; MALE; P-GLYCOPROTEIN; PRAZOSIN; RATS; RATS, SPRAGUE-DAWLEY; SUPPORT, NON-U.S. GOV'T; TIME FACTORS; TRITIUM;

EID: 0028788284     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(95)02073-X     Document Type: Article

References (40)

1. Pharmacology of drugs that alter multidrug resistance in cancer
2. Biochemistry of multidrug resistance mediated by the multidrug transporter
3. Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines
4. Amplification of P-glycoprotein genes in multi-drug-resistant mammalian cell lines
5. ATPase activity of partially purified P-glycoprotein from multidrug-resistant Chinese hamster ovary cells
6. High levels of P-glycoprotein detected in isolated brain capillaries
7. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites
8. Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: Evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein
9. Functional involvement of P-glycoprotein in blood-brain barrier
10. Expression and functional activity of P-glycoprotein in cultured cerebral capillary endothelial cells
11. The blood-brain barrier
12. Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability
13. Restrictive transport of a lipid-soluble peptide (cyclosporin) through the blood-brain barrier
14. Disruption of the mouse mdrla P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
15. Isoform I (mdr3) is the major form of P-glycoprotein expressed in mouse brain capillaries. Evidence for cross-reactivity of antibody C219 with an unrelated protein.
16. Restricted transport of cyclosporin A across the blood-brain barrier by a multidrug transporter, P-glycoprotein
17. Molecular targets in oncology: Implications of the multidrug resistance gene
18. Cyclosporins as drug resistance modifiers
19. In vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumor cells with SDZ PSC 833
20. The polyoxyethylene castor oil Cremophor EL modifies multidrug resistance
21. Reversal of multidrug resistance by surfactants
22. Purification and characterization of metabolically active capillaries of the blood-brain barrier
23. γ-Glutamyl-p-nitroanilide: a new convenient substrate for determination and study of l- and d-γ-glutamyltranspeptidase activities
24. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
25. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
26. P-glycoprotein of blood barrier: Cross-reactivity of MAb C219 with a 190 kDa protein in bovine and rat isolated brain capillaries
27. Photoaffinity probes for the α1-adrenergic receptor and the calcium channel bind to a common domain in P-glycoprotein
28. Differential transport properties of two mdr gene products are distinguished by progesterone
29. 3H]azidopine: Relation to lipophilicity and inhibition of daunorubicin transport in multidrug resistant cells
30. 125I]iodophenethyl)spiperone binds to specific regions of P-glycoprotein and another multidrug binding protein, spiperophilin, in human neuroblastoma cells
31. ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells
32. SDZ PSC 833, a non-immunosuppressive cyclosporine: Its potency in overcoming P-glycoprotein-mediated multidrug resistance of murine leukemia
33. Resistance modification by PSC-833, a novel non-immunosuppressive cyclosporin A
34. Reversal of typical multidrug resistance by cyclosporin and its non-immunosuppressive analogue SDZ PSC 833 in Chinese hamster ovary cells expressing the mdr1 phenotype
35. Pharmacokinetic profiles of cyclosporine in rats
36. Permeability of the blood-brain barrier to the immunosuppressive cyclic peptide cyclosporin A
37. Clinical trials of modulation of multidrug resistance
38. Increased mdr-1/P-glycoprotein expression after treatment of human colon carcinoma cells with P-glycoprotein antagonists
39. Derivation and characterization of a mouse tumour cell line with acquired resistance to cyclosporin A
40. Chemosensitisation by verapamil and cyclosporin A in mouse tumour cells expressing different levels of P-glycoprotein and CP22 (sorcin)